Statistics about Health, Pharma & Medtech in Australia
Statistics
- Drinking habits in Australia in 2019, by drinking behavior
- Share of youth engaging in risky drinking Australia from 2007-2019
- Current and former e-cigarette and vape use Australia FY 2021, by age group
- Incidents of illicit drug related abuse Australia 2019, by gender
- Number of deaths related to alcohol Australia 2021, by gender and associated cause
- Number of hospitalizations related to alcohol Australia FY 2016-2022
- Incidents of alcohol related abuse Australia 2019, by gender
- Share of workers with mental health issue working from home Australia 2020, by gender
- Distribution of early workers working from home in Australia 2020, by working time
- Breakdown of additional expenses incurred by homeworkers Australia 2020, by type
- Share of people aged 15 to 24 years old engaging in risky drinking Australia FY 2021
- Breakdown of total additional expenses incurred by homeworkers in Australia, 2020
- LGBTIQ+ persons negatively impacted mentally by COVID-19 Australia 2022, by gender
- Share of mental health issues faced while working from home Australia 2020, by gender
- Breakdown of additional expenses incurred reimbursed by employer Australia 2020
- E-cigarette and vape use Australia FY 2021, by age group
- LGBTIQ+ persons negatively impacted mentally by COVID-19 Australia 2022, by sexuality
- Share of people that used digital mental health services Australia FY 2021, by type
- Share of population with binge eating behaviors during lifetime Australia FY 2021
- E-cigarette and vape use by young people Australia FY 2021
- Reported change in consumption of alcohol Australia Apr 2020
- National AOD hotline calls during COVID-19 Australia Jan-Apr 2019-2020
- Mental disorder prevalence in the Australian population FY 2021, by classification
- Patterns and motivations for alcohol use during COVID-19 Australia 2020
- Value of pharmaceutical industry revenue Australia 2018 by sector
- Share of healthcare spend in life Australia 2017 by age
- Earnings per share of CSL Ltd Australia FY 2015-2019
- Total non current liabilities of CSL Ltd Australia FY 2014-2019
- Fatal opioid overdoses Australia by type 2016
- Fatal opium overdoses Australia 2013-2016
- Total non current assets of CSL Ltd Australia FY 2014-2019
- Total current liabilities of CSL Ltd Australia FY 2014-2019
- Number of employees pharmaceutical industry Australia 2018 by sector
- Total current assets of CSL Ltd Australia FY 2014-2019
- Net profit of CSL Ltd FY 2015-2022
- Change in turnover of pharmaceutical industry Australia 2018 by state
- Total operating revenue of CSL Ltd FY 2015-2022
- Total equity of CSL Ltd Australia FY 2014-2019
- Share of pharmacy revenue Australia 2018 by segment
- Number of establishments pharmaceutical industry Australia 2018 by sector
- R&D expenditure of CSL Ltd FY 2015-2022
- Share of adults worldwide who declared to be knowledgeable on AMR in 2022, by age
- Share of women using contraception Oceania 2020-2030, by country
- Industry revenue of “Human Pharmaceutical and Medicinal Product Manufacturing“ in Australia 2011-2023
- Number of diabetes prescriptions dispensed Australia FY 2021, by type of medicine
- Australian sales of herbal and traditional medicine products 2011-2015
- Australian sales of vitamin and dietary supplements 2011-2015
- Australian alternative health market revenue 2004-2016
- Australian alternative health consumer market share 2013-2014, by age
- Revenue of the complementary medicine industry Australia FY 2021, by type
- Most expensive prescription drugs Australia FY 2021, by cost to government
- Leading complementary medicines purchased Australia 2021
- Australian alternative health products and services market from 2013-2014, by segment
- Leading pharmaceutical companies listed on ASX Australia 2023
- U.S. prices of Revlimid compared to prices in select countries 2020
- U.S. prices of Janumet XR compared to prices in select countries 2020
- U.S. prices of Imbruvica compared to prices in select countries 2020
- U.S. net prices of Harvoni compared to gross prices in select countries 2020
- U.S. drug prices at manufacturer level compared to other countries by multiplier 2020
- U.S. drug prices at retail level compared to select countries by multiplier 2020
- Number of select Chinese medicine practitioners in Australia 2014 by region
- Avoided hospitalizations through CAM medicine use by condition in Australia 2015-2020
- Yearly financial benefits from complementary medicine use in Australia 2015-2020
- Revenue in the hand sanitizer segment Australia 2018-2029
- ARPU in the vitamins & minerals segment Australia 2018-2029
- Average revenue per unit (ARPU) in the OTC pharmaceuticals market Australia 2018-2029
- Most commonly used prescription drugs Australia FY 2023
- Pharma market revenue APAC 2023, by country
- Share of clinical trials in selected countries APAC 1999-2022, by health category
- Revenue in the vitamins & minerals segment Australia 2018-2029
- ARPU in the hand sanitizer segment Australia 2018-2029
- Subsidized drug expenditure in Australia FY 2016-2022
- Complementary medicines risk reduction in select conditions in Australia 2014
- OTC pharma market revenue APAC 2023, by country
- Average revenue per unit (ARPU) in the OTC Pharmaceuticals market Australia 2018-2029
- U.S. prices of Xarelto compared to prices in select countries 2020
- Benefit/cost ratio of complementary medicine use by condition in Australia 2014
- Australian sales of over-the-counter medicines 2011-2015
- Australians who paid for doctor and/or alternative health service 2014-2015
- Share of clinical trials in selected countries APAC 1999-2022, by participants
- Revenue in the OTC pharmaceuticals market Australia 2018-2029
- Australian sales of sports nutrition products 2011-2015
- Distribution of complementary medicine shop sales Australia FY 2021 by type
- Share of exported complementary medicines Australia 2021, by export region
- Number of PBS approved community pharmacies Australia 2022, by state and territory
- Growth of leading supplement ingredients Australia 2021
- Market share of leading supplement categories Australia FY 2019
- Most prescribed prescription drugs Australia FY 2021, by prescriptions
- Revenue of the complementary medicine sector Australia FY 2011-2021
- Most commonly used subsidized prescription drugs Australia 2015
- Prescriptions by type of service dispensed in Australia 2015
- Number of prescriptions in Australia - by type of service 2006-2015
- Sales revenue of Sigma Healthcare 2016-2022
- EBITDA of Sigma Healthcare 2016-2022
- People who visited pharmacists or chemists Australia 2019 by age group
- Males who visited pharmacists or chemists Australia 2019 by age group
- Number of general pharmacists Australia 2021 by state
- Females who visited pharmacists or chemists Australia 2019 by age group
- General pharmacists Australia 2019 by age group
- EBITDA of EBOS Group FY 2016-2022